Multicenter retrospective and prospective analysis of emicizumab and FVIII prophylaxis in children with severe hemophilia A

被引：0

作者：

Hassan, Tamer ^{[1
]}

Lotfy, Gehan ^{[2
]}

Elalfy, Omar ^{[3
]}

Amin, Mervat ^{[4
]}

Elmasry, Zahraa ^{[5
]}

Elhawary, Eslam ^{[6
]}

Darwish, Ahmed ^{[7
]}

Elalfy, Mohsen ^{[8
]}

机构：

[1] Zagazig Univ, Dept Pediat, Zagazig, Egypt

[2] Menia Univ, Menia, Egypt

[3] Natl Res Ctr, Complementary Med Dept, Cairo, Egypt

[4] Assiut Univ, Assiut, Egypt

[5] Sohag Univ, Sohag, Egypt

[6] Tanta Univ, Tanta, Egypt

[7] Mansoura Univ, Mansoura, Egypt

[8] Ain Shams Univ, Cairo, Egypt

来源：

HAEMOPHILIA | 2024年 / 30卷

关键词：

Hemophilia A; Factor VIII; Emicizumab;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

LBA-PP-004

引用

页码：222 / 223

页数：2

共 50 条

[21] A Phase IV, Multicenter, Open-Label Study of Emicizumab Prophylaxis in Persons with Hemophilia a with or without FVIII Inhibitors Undergoing Minor Surgical Procedures
Escobar, Miguel A.
Dunn, Amy
Quon, Doris
Trzaskoma, Ben
Lee, Lucy
Ko, Richard H.
Carpenter, Shannon L.
BLOOD, 2020, 136
[22] EMICIZUMAB FOR THE MANAGEMENT OF CHILDREN WITH SEVERE HEMOPHILIA A: EXPERIENCE FROM HEMOPHILIA CENTRES IN LITHUANIA
Trakymiene, Saulyte S.
Kiudeliene, R.
Rutkauskiene, G.
Rascon, J.
HAEMATOLOGICA, 2021, 106 (09) : 11 - 12
[23] ISTH Congress: Early Prophylaxis in Infants and Young Children with Hemophilia A with Emicizumab
Reisdorf, Simone
TRANSFUSION MEDICINE AND HEMOTHERAPY, 2024, 51 (05)
[24] Cost-Effectiveness of Emicizumab for Prophylaxis in People with Severe Hemophilia A without Inhibitors
Decker-Palmer, Marquita
Lin, Chia-Wei
Wilson, Michele
McDade, Cheryl
Bawa, Komal
Kowal, Stacey
Ravelo, Arliene
Yu, Elaine
Ko, Richard H.
BLOOD, 2022, 140 : 13041 - 13042
[25] Emicizumab Prophylaxis in Patients with Severe Hemophilia A: Insights from A Resource Limited Country
Borhany, Munira
Arshad, Aisha
Qureshi, Heeba
Nadeem, Rukhshanda
Jamal, Arif
Khan, Raheel Ahmed
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2024, 30
[26] Emicizumab Prophylaxis for the Treatment of Chinese Hemophilia A Patients in the Real World: A Multi-Center Retrospective Analysis
Xu, Yuan
Wang, Ying
Wu, Runhui
Zheng, Changcheng
Xiao, Jianwen
Xu, Weiqun
Feng, Xiaoqin
Wang, Hua
Cao, Xiangshan
He, Liya
Xue, Tianyang
Jin, Mingwei
Xie, Bingshou
Ling, Jing
Sun, Lirong
Su, Rui
Cheng, Hongbo
Fang, Yongjun
Li, Bai
Yu, Ziqiang
Xue, Ailing
Sun, Mei
Yang, Li
Zhou, Zeping
Zhou, Hu
Jin, Jiao
Zhou, Min
Chen, Rong
Liu, Wei
Zhang, Lei
Xue, Feng
Yang, Renchi
BLOOD, 2023, 142
[27] Maintaining Perioperative Hemostasis in Patients with Severe Hemophilia A and Inhibitors Receiving Emicizumab Prophylaxis
Zimowski, Karen L.
Batsuli, Glaivy M.
Reding, Mark T.
Rana, Jatin
Callaghan, Michael U.
Tickle, Kelly
Meeks, Shannon L.
Sidonio, Robert F., Jr.
BLOOD, 2018, 132
[28] Low-dose emicizumab prophylaxis in patients with severe hemophilia A: a retrospective study bringing new hope for our patients
Patil, Rucha
Shanmukhaiah, Chandrakala
Gogtay, Nithya J.
Pandey, Puloma
Patil, Kirti
Jijina, Farah
Madkaikar, Manisha
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (04) : 1024 - 1030
[29] BUDGET IMPACT ANALYSIS OF THE USE OF EMICIZUMAB IN PROPHYLAXIS FOR SEVERE HEMOPHILIA A AND INHIBITORS IN THE PEDIATRIC COPULATION OF THE DOMINICAN REPUBLIC
Munoz, A.
Bustamante, A.
Blanco, J.
VALUE IN HEALTH, 2022, 25 (12) : S135 - S136
[30] The Efficacy of Recombinant FVIII Low-Dose Prophylaxis in Chinese Pediatric Patients With Severe Hemophilia A: A Retrospective Analysis From the ReCARE Study
Yao, Wanru
Xiao, Juan
Cheng, Xiaoling
Feng, Guoshuang
Li, Changgang
Zhang, Xinsheng
Hu, Qun
Xu, Weiqun
Sun, Jing
Yang, Renchi
Li, Xiaojing
Zhou, Rongfu
Lian, Shimei
Gu, Jian
Wu, Junde
Zhao, Yongqiang
Wu, Runhui
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2017, 23 (07) : 851 - 858

← 1 2 3 4 5 →